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INTRODUCTION
Epidemiologic studies suggest that sleep duration may 
adversely affect one’s health in a number of ways. Inter-
estingly, both short and long sleep durations have been 
shown to be associated with increased risks of all-cause 
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Background/Aims: Sleep duration affects health in various ways. The objective of 
this study was to investigate the associations of sleep duration with chronic kid-
ney disease (CKD) in a Korean adult population.
Methods: This cross-sectional analysis was conducted for total of 1,360 partici-
pants who completed baseline health examinations for the Korean Genome and 
Epidemiology Study-Kangwha study in 2010 to 2011. Sleep habits were measured 
by an interviewer-assisted questionnaire. Sleep duration was calculated based on 
the number of hours per day participants had slept over the past 1 year. CKD was 
defined as either proteinuria or estimated glomerular filtration rate (eGFR) < 60 
mL/min/1.73 m². Multiple logistic regression models were applied to examine as-
sociations between sleep duration and CKD.
Results: Women with very long sleep duration (≥ 9 hours/day) were at significant-
ly increased odds for having high serum creatinine (odds ratio [OR], 2.936; 95% 
confidence interval [CI], 1.176 to 7.326), low eGFR (OR, 3.320; 95% CI, 1.372 to 8.034), 
and CKD (OR, 3.112; 95% CI, 1.315 to 7.363), compared those with a typical sleep 
duration (7 to < 8 hours/day), after adjusting for sociodemographic status, socio-
economic status, health behaviors, comorbidities, and sleep quality. Among wom-
en, for every 1 hour increase in sleep duration per day, there was a 24.6% increase 
in the presence of CKD (OR, 1.246; 95% CI, 1.019 to 1.523). However, among men, 
sleep duration was not significantly associated with CKD.
Conclusions: Very long sleep duration was independently associated with a high-
er prevalence of CKD among Korean women. Gender may influence this associa-
tion.
Keywords: Sleep duration; Sleep quantity; Renal insufficiency, chronic; Kidney 
function; General population 
Sleep duration and chronic kidney disease: 
The Korean Genome and Epidemiology Study 
(KoGES)-Kangwha study
Hansol Choi1,2, Hyeon Chang Kim2,3,4, Joo Young Lee3, Ju-Mi Lee3,4, Dong Phil Choi1,2, and Il Suh3
324 www.kjim.org https://doi.org/10.3904/kjim.2015.400
The Korean Journal of Internal Medicine Vol. 32, No. 2, March 2017
mortality, cardiovascular disease, and other chronic 
diseases [1-3]. Meanwhile, sleeping habits in the general 
population reflect a complexity of interactions related 
to the presence of comorbid medical conditions and 
physical, psychological, social, and lifestyle factors.
Chronic kidney disease (CKD) has emerged as a public 
health problem worldwide, with reports of increasing 
prevalence and adverse complications [4-7]. Moreover, 
CKD has been recognized as a predictor of end-stage 
kidney disease and cardiometabolic disease [4]. Nev-
ertheless, adverse outcomes of CKD can be prevented 
through early detection, education, treatment, and in-
tervention to modify harmful lifestyle factors [8,9]. In 
particular, changing one’s sleep duration may be effec-
tive in preventing CKD. Although cross-sectional and 
prospective epidemiologic studies have suggested that 
sleep quality is a significant risk factor for CKD [10,11], 
little is known of the association between sleep quantity 
and CKD [8,12,13]. While a few studies have suggested 
that sleep duration can influence kidney function, dis-
tinct associations remain unclear. Therefore, we aimed 
to investigate the relationships between sleep duration 
and CKD in a Korean adult population. 
METHODS
Study population
Data for the present study were derived from the Korean 
Genome and Epidemiology Study (KoGES)-Kangwha 
study, an ongoing rural community-based prospective 
cohort. During the baseline survey period from 2006 to 
2011, the KoGES-Kangwha study enrolled 4,899 com-
munity dwellers from Kangwha Island, Incheon, South 
Korea. Current cross-sectional analysis was conducted 
for a total of 1,360 participants who completed the ques-
tionnaire concerning sleep (544 men and 816 women 
aged 36 to 88 years) in 2010 to 2011. All participants pro-
vided written informed consent, and the Institutional 
Review Board of Severance Hospital, Yonsei University 
College of Medicine, approved the study protocol.
Measurements
Trained interviewers obtained information on the par-
ticipants’ demographic characteristics, socioeconomic 
status (household income, marital status, and working 
status), previously known diseases, medication use, 
and health behaviors (sleep, cigarette smoking, alcohol 
intake, and physical activity) using standardized ques-
tionnaires. Depressive symptoms were assessed using 
the Beck Depression Inventory (BDI), and depression 
was determined on the basis of BDI score of ≥ 16 or a 
self-reported physician’s diagnosis [14]. Smoking sta-
tus, alcohol consumption, and physical activity were 
categorized as either current or non-current.
Sleep habits were measured by an interviewer-assist-
ed questionnaire. Participants were asked to report the 
number of hours per day they had slept over the past 1 
year, including naps, whether they had trouble falling 
asleep, whether they had trouble getting back to sleep 
after they had awaken, snoring behaviors, and the pres-
ence of sleep apnea. In the present study, average sleep 
durations were defined as the total time in bed per day 
(calculated from bedtime, rise time, and naps). Partici-
pants were divided into five groups based upon their re-
ported sleep duration: < 6 hours/day, “very short sleep-
ers”; 6 to < 7 hours/day, “short sleepers”; 7 to < 8 hours/
day, “usual sleepers (reference group)”; 8 to < 9 hours/
day, “long sleepers”; and ≥ 9 hours/day, “very long sleep-
ers.”
All participants completed health examinations, in-
cluding anthropometric measurements, blood pressure 
measurements, blood laboratory tests, bone mineral 
density measurements, and electrocardiography. Body 
weight was measured to the nearest 0.1 kg on a digi-
tal scale (GL-60000-20, CAS Korea, Seoul, Korea), and 
standing height was measured to the nearest 0.1 cm on 
a stadiometer (SECA 225, SECA, Hamburg, Germany). 
Body mass index (BMI) was calculated as body weight 
(kg) divided by standing height (m²). Resting blood pres-
sures were measured twice at a 5-minute interval using 
an automatic sphygmomanometer (Dinamap 1846 SX/P, 
GE Healthcare, Waukesha, WI, USA). Additional mea-
surements were performed, if the first and second mea-
surements differed by ≥ 10 mmHg for either systolic or 
diastolic blood pressure, and the average of the last two 
measurements was used for analysis.
Fasting blood samples were collected from the ante-
cubital vein after at least an 8-hour fast. Blood samples 
were sent to an independent research laboratory center 
for analysis. Serum creatinine concentrations and blood 
urea nitrogen concentrations were measured by the col-
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orimetric methods, and serum concentrations of cho-
lesterol were measured by enzymatic methods with an 
automatic analyzer (ADVIA 1650, Siemens, Tarrytown, 
NY, USA in 2010; ADVIA 1800, Siemens in 2011). Dia-
betes mellitus was determined on the basis of fasting 
glucose concentration (≥ 126 mg/dL) or a self-reported 
physician’s diagnosis [15]. Hypercholesterolemia was de-
fined (according to the Korean Society of Lipidology and 
Atherosclerosis criteria) as a total cholesterol concentra-
tion ≥ 230 mg/dL [16], taking a lipid-lowering drug, or a 
self-reported physician’s diagnosis.
Kidney function was estimated by serum creatinine 
concentration, presence of proteinuria, and estimated 
glomerular filtration rate (eGFR). Serum creatinine con-
centration cutoffs were sex specific, corresponding to 
the study design, with cutoffs of > 1.3 mg/dL for men and 
> 1.0 mg/dL for women. The intra-assay coefficients of 
variation were 1.7% at 1.8 mg/dL and 1.3% at 8.4 mg/dL. 
The total coefficients of variation were 3.8% at 1.8 mg/
dL and 3.7% at 8.4 mg/dL. Proteinuria was diagnosed as 
1+ or more by semiquantitative dipstick test. An eGFR 
was calculated using the modification of diet in renal 
disease study equation [17] as follows: 186 × (creati-
nine/88.4)–1.154 × (age)–0.203 × (0.742 if female). The diag-
nosis of CKD was defined as either kidney damage or 
an eGFR of < 60 mL/min/1.73 m², according to criteria 
set by the National Kidney Foundation Kidney Disease 
Outcomes Quality Initiative [18].
Statistical analysis
The distribution of continuous variables was described 
as means with standard deviations and compared us-
ing one-way analysis of variance. Categorical variables 
were reported as observed numbers and percentages, 
and compared using the chi-square test. A general 
linear model using contrast coefficients was used for 
linear trend analysis of continuous variables, and Co-
chran-Armitage test and Mantel-Haenszel test were 
used for categorical variables. Multiple linear regres-
sion models were used to assess the independent as-
sociation between sleep duration and CKD. Sex, age, 
BMI, systolic blood pressure, smoking status, alcohol 
consumption, physical activity, diabetes mellitus, hy-
percholesterolemia, depression, history of cardiovas-
cular disease, history of cancer, menopausal status, so-
cioeconomic status (household income, marital status, 
and working status), and sleep quality (sleep difficulty, 
sleep awakeness, snoring, and sleep apnea) were con-
sidered as covariates in the model. In addition, mul-
tiple logistic regression models were used to estimate 
odds ratios (OR) with 95% confidence intervals (CI) for 
CKD criteria. We performed statistical analyses on the 
total population, as well as men and women separately, 
because we found significant sex differences in kidney 
function. We plotted serum creatinine concentration 
and eGFR versus average sleep duration expressed on 
a continuous scale using cubic spline models. In a sen-
sitivity analysis, we calculated age-specific sex-strat-
ified ORs for CKD across the average sleep duration. 
An additional multiple logistic regression analysis was 
conducted excluding participants with hypertension 
(n = 516), diabetes mellitus (n = 165), and a history of 
cardiovascular disease (n = 103). All statistical analyses 
were performed using SAS software version 9.2 (SAS, 
Cary, NC, USA), and statistical significance was defined 
as a two-sided p value of less than 0.05.
RESULTS
The baseline characteristics of all participants are 
presented in Table 1. Of 1,360 participants, there were 
130 very short sleepers (< 6 hours/day, 9.6%), 301 short 
sleepers (6 to < 7 hours/day, 22.1%), 458 usual sleepers (7 
to < 8 hours/day, 33.7%), 319 long sleepers (8 to < 9 hours/
day, 23.5%), and 152 very long sleepers (≥ 9 hours/day, 
11.2%). Among men, the percentages of participants 
who slept < 6 and ≥ 9 hours were 8.6% and 12.1%, re-
spectively. Among women, the corresponding percent-
ages were 10.2% and 10.5%, respectively. The number 
of participants with a very short sleep duration was 
greater for women than for men, and the number of 
participants with a very long sleep duration was small-
er for women than for men. The mean sleep duration 
was 431.4 minutes/day for men and 430.6 minutes/day 
for women. The mean serum creatinine concentration 
was 1.1 mg/dL for men and 0.9 mg/dL for women, and 
was thus significantly higher among men. The preva-
lence of high serum creatinine concentration was 7.4% 
among both men and women. The mean eGFR was 
76.0 mL/min/1.73 m² for men and 73.7 mL/min/1.73 m² 
for women, and was thus significantly higher among 
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Table 1. Baseline characteristics of the study population (n = 1,360)
Variable Total (n = 1,360) Men (n = 544) Women (n=816) p value
Age, yr 60.0 ± 10.3 61.5 ± 10.2 59.0 ± 10.2 < 0.001
Body mass index, kg/m² 24.5 ± 3.1 24.3 ± 3.0 24.7 ± 3.2 0.033
SBP, mmHg 118.2 ± 17.3 118.9 ± 16.2 117.7 ± 18.0 0.208
DBP, mmHg 71.4 ± 10.4 74.1 ± 10.0 69.6 ± 10.3 < 0.001
Sleep duration, min 430.9 ± 76.2 431.4 ± 76.2 430.6 ± 76.3 0.861
< 6 hours/day 130 (9.6) 47 (8.6) 83 (10.2)
6 to < 7 hours/day 301 (22.1) 127 (23.3) 174 (21.3)
7 to < 8 hours/day 458 (33.7) 185 (34.0) 273 (33.5)
8 to < 9 hours/day 319 (23.5) 119 (21.9) 200 (24.5)
≥ 9 hours/day 152 (11.2) 66 (12.1) 86 (10.5)
Sleep quality
Sleep difficulty (at least 1/week) 413 (30.4) 108 (19.9) 305 (37.4) < 0.001
Sleep awake (at least 1/week) 506 (37.2) 159 (29.2) 347 (42.5) < 0.001
Snoring 672 (49.4) 282 (51.8) 390 (47.8) 0.160
Sleep apnea 117 (8.6) 76 (14.0) 41 (5.0) < 0.001
Depression 176 (12.9) 56 (10.3) 120 (14.7) 0.022
Diabetes mellitus 165 (12.1) 84 (15.4) 81 (9.9) 0.003
Hypertension 516 (37.9) 212 (39.0) 304 (37.3) 0.561
Hypercholesterolemia 327 (24.0) 94 (17.3) 233 (28.6) < 0.001
History of cardiovascular disease 103 (7.6) 59 (10.8) 44 (5.4) < 0.001
History of cancer 53 (3.9) 14 (2.6) 39 (4.8) 0.055
Current drinker 519 (38.2) 324 (59.6) 195 (23.9) < 0.001
Current smoker 154 (11.3) 136 (25.0) 18 (2.2) < 0.001
Regular exercise 503 (37.0) 214 (39.3) 289 (35.4) 0.159
Low household income (> 1 million won) 580 (42.6) 197 (36.2) 383 (46.9) < 0.001
Single, divorced, or separated 200 (14.7) 29 (5.3) 171 (21.0) < 0.001
Unemployed or housewives 446 (32.8) 119 (21.9) 327 (40.1) < 0.001
Fasting glucose, mg/dL 98.4 ± 20.8 101.8 ± 24.4 96.1 ± 17.6 < 0.001
Total cholesterol, mg/dL 191.9 ± 33.9 184.2 ± 32.2 197.1 ± 34.1 < 0.001
HDL-C, mg/dL 46.3 ± 11.6 43.7 ± 10.8 48.1 ± 11.8 < 0.001
Triglycerides, mg/dL 148.2 ± 89.5 156.1 ± 101.2 143.0 ± 80.4 0.008
hs-CRP, mg/L 1.7 ± 5.3 1.9 ± 7.0 1.5 ± 3.7 0.196
Blood urea nitrogen, mg/dL 16.2 ± 4.8 17.0 ± 4.9 15.7 ± 4.6 < 0.001
Creatinine, mg/dL 0.9 ± 0.2 1.1 ± 0.2 0.9 ± 0.1 < 0.001
eGFR, mL/min/1.73 m² 74.6 ± 11.5 76.0 ± 12.4 73.7 ± 10.7 < 0.001
Proteinuria (≥ 1+) 15 (1.1) 8 (1.5) 7 (0.9) 0.430
High creatinine (> 1.3 men, > 1.0 women) 100 (7.4) 40 (7.4) 60 (7.4) 0.084
Low eGFR (< 60 mL/min/1.73 m²) 115 (8.5) 46 (8.5) 69 (8.5) 0.079
CKD 125 (9.2) 52 (9.6) 73 (8.9) 0.774
Values are presented as mean ± SD or number (%).
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; hs-CRP, high-sensi-
tivity C-reactive protein; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.
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men. The prevalence of low eGFR was 8.5% among both 
men and women. The overall prevalence of CKD was 
9.6% among men and 8.9% among women; the differ-
ence was not statistically significant. The prevalences 
of CKD according to stage are presented in Supplemen-
tary Table 1.
The general characteristics of the male and female 
participants are presented according to sleep duration 
category in Tables 2 and 3. In both men and women, 
mean age was highest among very long sleepers. In men, 
individuals with a very long sleep duration were more 
likely to be short, weigh less, and comprise a higher 
frequency of unemployed men. Among men, we noted 
no significant associations between sleep duration and 
serum creatinine concentration, eGFR, and CKD preva-
lence. In women, individuals with a very long duration 
were more likely to have a lower BMI, a higher frequen-
cy of menopause, and the lowest household income. 
Moreover, among women, we observed significantly dif-
ferent distributions for serum creatinine levels, eGFR, 
and CKD prevalence according to sleep duration. Nev-
ertheless, in both men and women, very long sleepers 
showed the highest prevalences of CKD.
Table 4 showed the result of the multiple linear re-
gression analysis of the associations between sleep du-
ration and CKD. Adjusted ORs for kidney functions and 
its components were estimated in separate models with 
average sleep duration assessed as a continuous variable 
in one and a categorical variable in the other. Among 
women, the longest sleep duration was significantly as-
sociated with high serum creatinine concentrations, low 
eGFR, and presence of CKD in the unadjusted model. Af-
ter additional adjustment for sociodemographic status, 
socioeconomic status, health behaviors, comorbidities, 
and sleep quality, the associations remained significant. 
Women who slept ≥ 9 hours/day showed significantly 
increased odds for having high serum creatinine con-
centrations (OR, 2.936; 95% CI, 1.176 to 7.326), low eGFR 
(OR, 3.320; 95% CI, 1.372 to 8.034), and CKD (OR, 3.112; 
95% CI, 1.315 to 7.363), compared to the reference group 
(sleep duration of 7 to < 8 hours/day). Among women, for 
every 1 hour increase in sleep duration per day, there was 
a 24.6% increase in the presence of CKD after adjusting 
for covariates. As a further visual cue, cubic splines were 
used to display the relationship between average sleep 
duration and kidney function (Supplementary Fig. 1). 
Women who slept more than 8 hours per day exhibited 
higher serum creatinine concentration and lower eGFR 
than the reference group. As shown in Fig. 1, the ORs 
(95% CI) for high serum creatinine concentration, low 
eGFR, and presence of CKD was the highest among fe-
male very long sleepers. Among men, there were no sig-
nificant associations between sleep duration and high 
serum creatinine concentration, low eGFR, and pres-
ence of CKD.
In the sensitivity analysis (Supplementary Tables 2 
and 3), we found that sleeping more than 8 hours was 
significantly associated with CKD (OR, 2.699; 95% CI, 
1.065 to 6.841) in women of older age (60 years or old-
er) when stratified according to the median age. Among 
younger women (less than 60 years), there were no sig-
nificant associations between sleep duration and kidney 
function; however, increases in average sleep duration 
tended to increase the risk for CKD. Additionally, we 
repeated the logistic regression analysis after excluding 
participants with hypertension, diabetes mellitus, and a 
history of cardiovascular disease (Supplementary Table 
4), and the association trend was quite consistent.
DISCUSSION
We investigated the associations between sleep dura-
tion and CKD in a Korean adult population. Herein, 
sleeping more than 9 hours was significantly associ-
ated with CKD in women; however, sleep duration was 
not significantly associated with CKD in men.
In recent decades, the average sleep duration in most 
individuals has reduced, and many studies have in-
vestigated shorter sleep durations and their effects on 
health. In particular, the average sleep duration of Ko-
reans was 7 hours and 49 minutes per day, which was 
the lowest among 18 OECD (Organisation for Economic 
Co-operation and Development) member countries [19]. 
Notwithstanding, epidemiological evidence of associa-
tions between sleep duration and CKD is insufficient. 
Previous studies reported that sleeping less than 5 hours 
was associated with proteinuria in the Japanese pop-
ulation [8,20] and higher risk of CKD among the shift 
workers [13]. More recently, an increasing number of 
studies have linked prolonged sleep duration with poor 
health effects [21,22]. However, studies have yet to iden-
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tify whether these same relationships exists in people 
who sleep longer.
In the present study of 1360 Koreans, the overall prev-
alence of CKD was 9.2% (9.6% for men and 8.9% in 
women), similar to other results. According to data from 
the National Health and Nutrition Examination Surveys 
Table 2. Characteristics of the study participants according to sleep duration in men (n = 544)
Variable
Sleep duration
p value
p for 
trend< 6 (n = 47) 6 to < 7 (n = 127) 7 to < 8 (n = 185) 8 to < 9 (n = 119) ≥ 9 (n = 66)
Age, yr 59.4 ± 10.6 59.5 ± 10.4 61.4 ± 9.8 62.3 ± 9.2 65.6 ± 11.2 0.001 < 0.001
Body mass index, kg/m² 24.2 ± 3.5 24.3 ± 3.0 24.6 ± 2.9 24.1 ± 3.1 23.9 ± 2.7 0.424 0.510
SBP, mmHg 117.4 ± 16.0 118.4 ± 14.9 119.1 ± 15.5 119.0 ± 17.3 120.0 ± 18.4 0.935 0.387
DBP, mmHg 73.2 ± 10.6 74.1 ± 10.6 73.7 ± 9.1 75.1 ± 9.7 73.6 ± 11.1 0.765 0.714
Sleep duration, min 290.9 ± 38.4 368.0 ± 13.6 428.1 ± 13.3 487.2 ± 13.2 561.8 ± 33.1 < 0.001 < 0.001
Sleep difficulty (at least 1/week) 17 (36.2) 29 (22.8) 31 (16.8) 13 (10.9) 18 (27.3) 0.001 0.058
Sleep awakeness (at least 1/week) 17 (36.2) 35 (27.6) 55 (29.7) 33 (27.7) 19 (28.8) 0.840 0.573
Snoring 29 (61.7) 68 (53.5) 91 (49.2) 63 (52.9) 31 (47.0) 0.528 0.209
Sleep apnea 8 (17.0) 20 (15.7) 25 (13.5) 16 (13.4) 7 (10.6) 0.848 0.265
Depression 6 (12.8) 8 (6.3) 10 (5.4) 8 (6.7) 6 (9.1) 0.451 0.755
Diabetes mellitus 6 (12.8) 14 (11.0) 27 (14.6) 26 (21.8) 11 (16.7) 0.194 0.069
Hypertension 21 (44.7) 42 (33.1) 69 (37.3) 52 (43.7) 28 (42.4) 0.384 0.339
Hypercholesterolemia 7 (14.9) 20 (15.7) 36 (19.5) 22 (18.5) 9 (13.6) 0.783 0.935
History of cardiovascular disease 4 (8.5) 7 (5.5) 25 (13.5) 16 (13.4) 7 (10.6) 0.185 0.152
History of cancer 2 (4.3) 1 (0.8) 5 (2.7) 5 (4.2) 1 (1.5) 0.447 0.769
Current drinker 26 (55.3) 78 (61.4) 117 (63.2) 65 (54.6) 38 (57.6) 0.577 0.596
Current smoker 11 (23.4) 35 (27.6) 44 (23.8) 27 (22.7) 19 (28.8) 0.827 0.965
Regular exercise 18 (38.3) 58 (45.7) 68 (36.8) 53 (44.5) 17 (25.8) 0.058 0.145
Low household income
 (> 1 million won)
20 (42.6) 48 (37.8) 59 (31.9) 40 (33.6) 30 (45.5) 0.264 0.929
Single, divorced, or separated 4 (8.5) 10 (7.9) 6 (3.2) 3 (2.5) 6 (9.1) 0.096 0.438
Unemployed or housewives 8 (17.0) 23 (18.1) 38 (20.5) 26 (21.8) 24 (36.4) 0.040 0.009
Fasting glucose, mg/dL 98.4 ± 28.7 100.4 ± 23.8 102.5 ± 23.5 101.7 ± 22.4 105.5 ± 28.5 0.558 0.115
Total cholesterol, mg/dL 183.9 ± 32.0 185.6 ± 31.2 184.7 ± 32.0 182.9 ± 34.0 182.3 ± 32.3 0.947 0.697
HDL-C, mg/dL 44.0 ± 10.6 43.7 ± 11.2 43.9 ± 10.7 43.9 ± 11.0 42.5 ± 10.5 0.911 0.490
Triglycerides, mg/dL 141.4 ± 80.4 163.1 ± 114.7 158.3 ± 99.6 156.4 ± 100.2 147.1 ± 94.2 0.700 0.859
hs-CRP, mg/L 1.6 ± 2.3 2.0 ± 7.7 1.5 ± 2.4 2.8 ± 12.3 1.3 ± 1.8 0.516 0.967
Blood urea nitrogen, mg/dL 17.4 ± 4.9 16.5 ± 4.6 16.9 ± 4.6 17.4 ± 5.6 17.6 ± 5.1 0.441 0.545
Creatinine, mg/dL 1.1 ± 0.1 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.2 1.1 ± 0.2 0.919 0.415
eGFR, mL/min/1.73 m² 77.2 ± 12.4 76.8 ± 10.7 75.6 ± 11.5 76.3 ± 15.1 74.1 ± 12.6 0.598 0.172
Proteinuria (≥ 1+) 0 2 (1.6) 3 (1.6) 2 (1.7) 1 (1.5) 0.941 0.624
High creatinine (> 1.3 mg/dL) 3 (6.4) 5 (3.9) 17 (9.2) 10 (8.4) 5 (7.6) 0.501 0.324
Low eGFR (< 60 mL/min/1.73 m²) 3 (6.4) 7 (5.5) 18 (9.7) 11 (9.2) 7 (10.6) 0.634 0.197
CKD 3 (6.4) 9 (7.1) 20 (10.8) 12 (10.1) 8 (12.1) 0.677 0.192
Values are presented as mean ± SD or number (%).
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; hs-CRP, high-sensi-
tivity C-reactive protein; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.
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Table 3. Characteristics of the study participants according to sleep duration in women (n = 816)
Variable
Sleep duration
p value
p for 
trend< 6 (n = 83)
6 to < 7 
(n = 174)
7 to < 8
 (n = 273)
8 to < 9 
(n = 200)  ≥ 
9 (n = 86)
Age, yr 59.8 ± 10.0 57.7 ± 10.6 57.2 ± 9.8 60.1 ± 9.6 63.6 ± 10.5 < 0.001 0.004 
Body mass index, kg/m² 25.1 ± 3.2 25.0 ± 3.3 24.4 ± 3.2 24.8 ± 3.1 24.1 ± 3.2 0.085 0.030 
SBP, mmHg 117.6 ± 19.9 117.4 ± 17.7 116.2 ± 17.6 119.4 ± 17.2 119.5 ± 19.7 0.339 0.385 
DBP, mmHg 69.4 ± 11.4 69.3 ± 10.3 69.2 ± 10.3 70.2 ± 10.0 70.3 ± 10.1 0.795 0.501 
Sleep duration, min 297.3 ± 40.9 368.4 ± 13.6 428.0 ± 13.5 484.8 ± 11.1 567.6 ± 42.0 < 0.001 < 0.001
Sleep difficulty (at least 1/week) 45 (54.2) 70 (40.2) 92 (33.7) 66 (33.0) 32 (37.2) 0.008 0.007 
Sleep awakeness (at least 1/week) 49 (59.0) 76 (43.7) 103 (37.7) 74 (37.0) 45 (52.3) 0.001 0.140 
Snoring 43 (51.8) 93 (53.4) 124 (45.4) 91 (45.5) 39 (45.3) 0.405 0.118 
Sleep apnea 2 (2.4) 10 (5.7) 11 (4.0) 13 (6.5) 5 (5.8) 0.563 0.296 
Depression 14 (16.9) 22 (12.6) 26 (9.5) 28 (14.0) 12 (14.0) 0.375 0.852 
Diabetes mellitus 9 (10.8) 20 (11.5) 25 (9.2) 16 (8.0) 11 (12.8) 0.671 0.743 
Hypertension 39 (47.0) 73 (42.0) 84 (30.8) 70 (35.0) 38 (44.2) 0.017 0.280 
Hypercholesterolemia 25 (30.1) 56 (32.2) 72 (26.4) 61 (30.5) 19 (22.1) 0.407 0.270 
History of cardiovascular dis-
ease
2 (2.4) 8 (4.6) 14 (5.1) 14 (7.0) 6 (7.0) 0.535 0.093 
History of cancer 2 (2.4) 9 (5.2) 15 (5.5) 9 (4.5) 4 (4.7) 0.839 0.721 
Menopause 67 (80.7) 127 (73.0) 201 (73.6) 168 (84.0) 76 (88.4) 0.004 0.011 
Current drinker 20 (24.1) 39 (22.4) 72 (26.4) 45 (22.5) 19 (22.1) 0.826 0.792 
Current smoker 0 2 (1.1) 11 (4.0) 5 (2.5) 0 0.061 0.630 
Regular exercise 32 (38.6) 70 (40.2) 97 (35.5) 64 (32.0) 26 (30.2) 0.386 0.058 
Low household income (> 1 mil-
lion won)
41 (49.4) 73 (42.0) 114 (41.8) 103 (51.5) 52 (60.5) 0.012 0.022 
Single, divorced, or separated 20 (24.1) 33 (19.0) 47 (17.2) 43 (21.5) 28 (32.6) 0.037 0.143 
Unemployed or housewives 33 (39.8) 75 (43.1) 108 (39.6) 71 (35.5) 40 (46.5) 0.416 0.859 
Fasting glucose, mg/dL 100.1 ± 27.0 96.2 ± 20.0 95.6 ± 15.7 94.3 ± 12.2 97.3 ± 16.4 0.134 0.217 
Total cholesterol, mg/dL 205.0 ± 31.2 196.4 ± 37.1 193.7 ± 30.6 200.8 ± 35.2 193.5 ± 37.0 0.033 0.064 
HDL-C, mg/dL 49.7 ± 13.2 48.3 ± 10.7 48.3 ± 11.8 47.4 ± 11.3 47.2 ± 13.5 0.571 0.131 
Triglycerides, mg/dL 137.0 ± 61.1 139.9 ± 92.4 142.5 ± 81.6 147.6 ± 77.6 145.4 ± 74.8 0.835 0.390 
hs-CRP, mg/L 1.4 ± 2.7 1.4 ± 2.7 1.4 ± 2.9 1.5 ± 2.7 2.3 ± 8.0 0.332 0.101 
Blood urea nitrogen, mg/dL 15.7 ± 4.5 16.0 ± 4.9 15.3 ± 4.1 15.6 ± 4.6 16.4 ± 5.4 0.300 0.416 
Creatinine, mg/dL 0.9 ± 0.1 0.9 ± 0.1 0.8 ± 0.1 0.9 ± 0.1 0.9 ± 0.2 0.006 0.023 
eGFR, mL/min/1.73 m² 73.6 ± 10.1 73.8 ± 11.3 75.3 ± 10.2 72.7 ± 9.2 70.5 ± 13.8 0.003 0.039 
Proteinuria (≥ 1+) 0 1 (0.6) 2 (0.7) 3 (1.5) 1 (1.2) 0.732 0.208 
High creatinine (> 1.0 mg/dL) 2 (2.4) 15 (8.6) 12 (4.4) 17 (8.5) 14 (16.3) 0.002 0.005 
Low eGFR (< 60 mL/min/1.73 m²) 5 (6.0) 15 (8.6) 13 (4.8) 19 (9.5) 17 (19.8) 0.001 0.005 
CKD 5 (6.0) 15 (8.6) 14 (5.1) 22 (11.0) 17 (19.8) 0.001 0.002 
Values are presented as mean ± SD or number (%).
SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high density lipoprotein cholesterol; hs-CRP, high-sensi-
tivity C-reactive protein; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease.
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Table 4. Association between sleep duration and chronic kidney disease criteria
Sleep duration Total no. No. (%) Unadjusted OR (95% CI) Adjusted OR (95% CI)a
High creatinine
Men
Continuous, hr/dayb 544 52 (9.6) 1.114 (0.864–1.436) 1.099 (0.832–1.452)
Categorical, hr/day
< 6 47 3 (6.4) 0.674 (0.189–2.403) 0.608 (0.146–2.534)
6 to < 7 127 5 (3.9) 0.405 (0.145–1.128) 0.265 (0.079–0.893)
7 to < 8 185 17 (9.2) 1.000 1.000
8 to < 9 119 10 (8.4) 0.907 (0.400–2.053) 1.011 (0.404–2.534)
≥ 9 66 5 (7.6) 0.810 (0.287–2.290) 0.541 (0.164–1.780)
Women
Continuous, hr/dayb 816 73 (8.9) 1.324 (1.078–1.625) 1.258 (1.012–1.564)
Categorical, hr/day
< 6 83 2 (2.4) 0.537 (0.118–2.449) 0.476 (0.097–2.341)
6 to < 7 174 15 (8.6) 2.052 (0.937–4.495) 1.767 (0.743–4.202)
7 to < 8 273 12 (4.4) 1.000 1.000
8 to < 9 200 17 (8.5) 2.020 (0.942–4.332) 1.703 (0.730–3.972)
≥ 9 86 14 (16.3) 4.229 (1.874–9.545) 2.936 (1.176–7.326)
Low eGFR
Men
Continuous, hr/dayb 544 52 (9.6) 1.190 (0.938–1.511) 1.145 (0.878–1.494)
Categorical, hr/day
< 6 47 3 (6.4) 0.633 (0.178–2.245) 0.514 (0.115–2.296)
6 to < 7 127 7 (5.5) 0.541 (0.219–1.336) 0.493 (0.177–1.369)
7 to < 8 185 18 (9.7) 1.000 1.000
8 to < 9 119 11 (9.2) 0.945 (0.430–2.078) 1.131 (0.460–2.782)
≥ 9 66 7 (10.6) 1.101 (0.438–2.768) 0.709 (0.236–2.132)
Women
Continuous, hr/dayb 816 73 (8.9) 1.301 (1.073–1.579) 1.222 (0.994–1.503)
Categorical, hr/day
< 6 83 5 (6.0) 1.282 (0.443–3.708) 1.161 (0.362–3.719)
6 to < 7 174 15 (8.6) 1.887 (0.875–4.069) 1.641 (0.688–3.916)
7 to < 8 273 13 (4.8) 1.000 1.000
8 to < 9 200 19 (9.5) 2.099 (1.011–4.359) 1.692 (0.743–3.849)
≥ 9 86 17 (19.8) 4.928 (2.283–10.636) 3.320 (1.372–8.034)
Chronic kidney disease
Men
Continuous, hr/dayb 544 52 (9.6) 1.182 (0.943–1.482) 1.091 (0.845–1.410)
Categorical, hr/day
< 6 47 3 (6.4) 0.563 (0.160–1.980) 0.453 (0.102–2.009)
6 to < 7 127 9 (7.1) 0.629 (0.277–1.431) 0.603 (0.235–1.545)
7 to < 8 185 20 (10.8) 1.000 1.000
8 to < 9 119 12 (10.1) 0.925 (0.434–1.970) 1.041 (0.435–2.489)
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(NHANES) in the United States, the overall prevalences 
of CKD were 10.0% in 1988 to 1994 and 13.1% in 1999 to 
2004 [4]. The overall prevalences of CKD in Asian adult 
populations are 12.9% in Japan [5] and 10.8% in China 
[6]. The overall prevalence of CKD in the Korea National 
Health and Nutrition Examination Survey (KNHANES) I 
to IV ranges from 3.9% to 7.9% in men and 6.3% to 12.0% 
in women, respectively [7].
Although plausible biological mechanisms for the re-
lationship between short sleep duration and CKD have 
been proposed, it is less clear as to how long sleep du-
ration is associated with CKD prevalence. The temporal 
associations between sleep duration and CKD are likely 
to be bi-directional; nevertheless, as long sleep duration 
could be either an initial symptom or a consequence of 
unmeasured diseases and conditions among CKD pa-
tients, any causality cannot be inferred from the pres-
ent data. Previous studies have also suggested that the 
association of long sleep duration with CKD could be 
explained by residual confounding and comorbidities 
[3,23]. Accordingly, potential confounders could predis-
pose individuals to both long sleep duration and poor 
kidney function. Thus, to reduce the effects of unmea-
sured confounders on our results, we adjusted for so-
ciodemographic status, socioeconomic status, health 
behaviors, comorbidities, and sleep quality, which may 
link long sleep duration to CKD. Even after adjusting for 
these confounders, the association between a long sleep 
duration and CKD remained significant. Notwithstand-
ing, the adverse health outcomes of long sleep duration 
and CKD share a few commonalities, including associ-
ations with old age, diabetes, established cardiovascular 
disease, high blood pressure, obesity, and smoking [24]. 
Interestingly, sleep duration has been shown to be asso-
ciated with cardiometabolic diseases by worsening kid-
ney hemodynamics and may lead to the development of 
glomerulosclerosis and glomerulomegaly [24-30]. 
A number of mechanisms could potentially mediate 
the associations between long sleep duration and kid-
ney dysfunction, encompassing both biological and 
socioeconomic factors. Inflammation has been shown 
to affect the relationship between long sleep duration 
and kidney dysfunction [12]. Indeed, several studies have 
indicated that immune dysfunction may lead to pro-
gressive kidney dysfunction through activation of the 
renin-angiotensin-aldosterone system, which is a well-
known regulator of blood pressure and a progression 
factor in CKD [27,29,31-33]. In addition, lower socioeco-
nomic status could be detrimental to CKD [23,34]. In the 
Nurses’ Health Study II, women who had never married, 
lived alone, were unemployed, had low household in-
come, and were of low societal status were more likely 
to sleep longer [23]. Meanwhile, lower socioeconomic 
status could increase the risk for CKD due to both a lack 
of access to health care and receipt of poorer quality of 
care [23]. For people with CKD, lower socioeconomic 
status may contribute to poor control of hypertension 
and diabetes mellitus due to lack of understanding of 
Sleep duration Total no. No. (%) Unadjusted OR (95% CI) Adjusted OR (95% CI)a
≥ 9 66 8 (12.1) 1.138 (0.475–2.724) 0.591 (0.199–1.760)
Women
Continuous, hr/dayb 816 73 (8.9) 1.319 (1.092–1.592) 1.246 (1.019–1.523)
Categorical, hr/day
< 6 83 5 (6.0) 1.186 (0.414–3.396) 1.076 (0.341–3.393)
6 to < 7 174 15 (8.6) 1.745 (0.821–3.712) 1.475 (0.635–3.428)
7 to < 8 273 14 (5.1) 1.000 1.000
8 to < 9 200 22 (11.0) 2.287 (1.139–4.589) 1.929 (0.885–4.204)
≥ 9 86 17 (19.8) 4.558 (2.141–9.703) 3.112 (1.315–7.363)
OR, odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate.
aAdjusted model: adjusted for sex, age, body mass index, systolic blood pressure, smoking, alcohol, exercise, diabetes mellitus, 
hypercholesterolemia, depression, history of cancer, menopause, socioeconomic status (household income, marital status, 
and working status), and sleep quality (sleep difficulty, sleep awakeness, snoring, and sleep apnea).
bContinuous model: association analysis on total sleep duration as a continuous variable.
Table 4. continued
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the disease or inadequate treatment [34]. Finally, longer 
hours spent in bed lead to reduced physical activity and 
could induce a prothrombotic state [23]. Increased phys-
ical activity exerts a protective effect against CKD by re-
ducing cardiometabolic risk factors [9,28]. In fact, an ex-
perimental study found that repeated exercise increased 
High creatinine (men)
Sleep duration (hr)
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
< 6   6 to < 7 7 to < 8 8 to < 9 ≥ 9
 High creatinine (women)
Sleep duration (hr)
9
8
7
6
5
4
3
2
1
0
< 6   6 to < 7 7 to < 8 8 to < 9 ≥ 9
Low eGFR (men)
Sleep duration (hr)
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
< 6   6 to < 7 7 to < 8 8 to < 9 ≥ 9
Low eGFR (women)
Sleep duration (hr)
9
8
7
6
5
4
3
2
1
0
< 6   6 to < 7 7 to < 8 8 to < 9 ≥ 9
CKD (men)
Sleep duration (hr)
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0
< 6   6 to < 7 7 to < 8 8 to < 9 ≥ 9
CKD (women)
Sleep duration (hr)
9
8
7
6
5
4
3
2
1
0
< 6   6 to < 7 7 to < 8 8 to < 9 ≥ 9
Figure 1. Association between sleep duration and chronic kidney disease (CKD). (A) Association between sleep duration and 
high creatinine in men. (B) Association between sleep duration and high creatinine in women. (C) Association between sleep 
duration and low estimated glomerular filtration rate (eGFR) in men. (D) Association between sleep duration and low eGFR in 
women. (E) Association between sleep duration and CKD in men. (F) Association between sleep duration and CKD in women.
CKD was defined as the presence of at least one of the following factors: eGFR than 60 mL/min/1.73 m2 or proteinuria. Adjusted 
model: adjusted for sex, age, body mass index, systolic blood pressure, smoking, alcohol, physical activity, diabetes mellitus, hy-
percholesterolemia, depression, history of cardiovascular disease, history of cancer, menopause, socioeconomic status (house-
hold income, marital status, and working status), and sleep quality (sleep difficulty, sleep awakeness, snoring, and sleep apnea).
A
C
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B
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GFR along with a reduction in renal mass in mice [35].
There are several limitations to this study that should 
be noted. As noted above, the main limitation of the 
present study relates to its causal relationship between 
the sleep duration and CKD cannot be confirmed due 
to the cross-sectional design of the study. Although we 
controlled for several potential confounders in our sta-
tistical models, residual confounding effects may have 
been present. Second, sleep habits were measured by 
a self-reported questionnaire and were not objectively 
confirmed. In future studies, objective measurements, 
including actigraphy and polysomnography to assess 
quality and quantity of sleep, would be needed. Third, 
we did not use 24-hour urinary albumin excretion, 
which is the gold standard test for assessing proteinuria. 
Instead, we measured proteinuria by a semiquantitative 
dipstick test, which has lower sensitivity and specificity, 
compared with urinary albumin test [23]. Finally, we did 
not exclude individuals who reported a history of chron-
ic diseases, such as hypertension, diabetes mellitus, and 
cardiovascular disease, which may have influenced the 
results. Further longitudinal analyses are required to 
delineate the possible role of long sleep duration in 
CKD among Korean adults.
In summary, we suggest that very long sleep duration 
is associated with CKD in community-dwelling Kore-
an women. Longitudinal analyses are required to clarify 
the roles of sleep quantity, as well as sleep quality, in 
maintaining and improving overall health among CKD 
patients. As sleep duration is a potentially modifiable 
risk factor, our results may help health advisors with 
preventing and delaying the progression of CKD. 
Conflict of interest
No potential conflict of interest relevant to this article 
was reported.
Acknowledgments 
This work was supported by the Research Program 
funded by the Korea Centers for Disease Control and 
Prevention (2010-E71003-00, 2011-E71002-00) and the 
Korean Health Technology R&D Project, Ministry of 
Health and Welfare (HI13C0715).
REFERENCES
1. Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep 
duration and all-cause mortality: a systematic review and 
meta-analysis of prospective studies. Sleep 2010;33:585-
592.
2. Knutson KL. Sleep duration and cardiometabolic risk: a 
review of the epidemiologic evidence. Best Pract Res Clin 
Endocrinol Metab 2010;24:731-743. 
3. Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller 
MA. Sleep duration predicts cardiovascular outcomes: a 
systematic review and meta-analysis of prospective stud-
ies. Eur Heart J 2011;32:1484-1492.
4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic 
kidney disease in the United States. JAMA 2007;298:2038-
2047.
5. Imai E, Horio M, Watanabe T, et al. Prevalence of chronic 
kidney disease in the Japanese general population. Clin 
Exp Nephrol 2009;13:621-630. 
6. Zhang L, Wang F, Wang L, et al. Prevalence of chronic 
kidney disease in China: a cross-sectional survey. Lancet 
2012;379:815-822. 
7. Kang HT, Lee J, Linton JA, Park BJ, Lee YJ. Trends in the 
prevalence of chronic kidney disease in Korean adults: 
the Korean National Health and Nutrition Examina-
tion Survey from 1998 to 2009. Nephrol Dial Transplant 
2013;28:927-936.
8. Fujibayashi K, Fukuda H, Yokokawa H, et al. Associations 
between healthy lifestyle behaviors and proteinuria and 
the estimated glomerular filtration rate (eGFR). J Athero-
scler Thromb 2012;19:932-940. 
9. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, 
Brancati FL. Lifestyle factors, obesity and the risk of 
chronic kidney disease. Epidemiology 2003;14:479-487.
10. Iliescu EA, Yeates KE, Holland DC. Quality of sleep in pa-
tients with chronic kidney disease. Nephrol Dial Trans-
plant 2004;19:95-99.
11. Ozkok A, Kanbay A, Odabas AR, Covic A, Kanbay M. 
KEY MESSAGE
1. Very long sleep duration (more than 9 hours) 
was significantly associated with chronic kidney 
disease (CKD) in community-dwelling Korean 
women.
2. Among women, for every one hour increase in 
sleep duration per day, there was a 24.6% in-
crease in the presence of CKD.
334 www.kjim.org https://doi.org/10.3904/kjim.2015.400
The Korean Journal of Internal Medicine Vol. 32, No. 2, March 2017
Obstructive sleep apnea syndrome and chronic kidney 
disease: a new cardiorenal risk factor. Clin Exp Hypertens 
2014;36:211-216.
12. Ohkuma T, Fujii H, Iwase M, et al. Association between 
sleep duration and urinary albumin excretion in patients 
with type 2 diabetes: the Fukuoka diabetes registry. PLoS 
One 2013;8:e78968.
13. Sasaki S, Yoshioka E, Saijo Y, Kita T, Tamakoshi A, Kishi 
R. Short sleep duration increases the risk of chronic 
kidney disease in shift workers. J Occup Environ Med 
2014;56:1243-1248.
14. Jo SA, Park MH, Jo I, Ryu SH, Han C. Usefulness of Beck 
Depression Inventory (BDI) in the Korean elderly popu-
lation. Int J Geriatr Psychiatry 2007;22:218-223. 
15. American Diabetes Association. Diagnosis and classifi-
cation of diabetes mellitus. Diabetes Care 2011;34 Suppl 
1:S62-S69.
16. Son JI, Chin SO, Woo JT; The Committee for Developing 
Treatment Guidelines for Dyslipidemia, Korean Society 
of Lipidology and Atherosclerosis (KSLA). Treatment 
guidelines for dyslipidemia: summary of the expanded 
second version. J Lipid Atheroscler 2012;1:45-59.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. 
A more accurate method to estimate glomerular filtration 
rate from serum creatinine: a new prediction equation. 
Modification of Diet in Renal Disease Study Group. Ann 
Intern Med 1999;130:461-470.
18. National Kidney Foundation. K/DOQI clinical practice 
guidelines for chronic kidney disease: evaluation, clas-
sification, and stratification. Am J Kidney Dis 2002;39(2 
Suppl 1):S1-S266. 
19. Organisation for Economic Co-operation and Devel-
opment (OECD). Society at a Glance 2009. Paris: OECD 
Publishing, 2009.
20. Yamamoto R, Nagasawa Y, Iwatani H, et al. Self-reported 
sleep duration and prediction of proteinuria: a retrospec-
tive cohort study. Am J Kidney Dis 2012;59:343-355.
21. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler 
MR. Mortality associated with sleep duration and insom-
nia. Arch Gen Psychiatry 2002;59:131-136.
22. Patel SR, Ayas NT, Malhotra MR, et al. A prospective study 
of sleep duration and mortality risk in women. Sleep 
2004;27:440-444.
23.  Patel SR, Malhotra A, Gottlieb DJ, White DP, Hu FB. Cor-
relates of long sleep duration. Sleep 2006;29:881-889. 
24. Kidney Health Australia. Chronic Kidney Disease (CKD) 
Management in General Practice. 2nd ed. Melbourne: 
Kidney Health Australia, 2012.
25. Chen J, Muntner P, Hamm LL, et al. Insulin resistance 
and risk of chronic kidney disease in nondiabetic US 
adults. J Am Soc Nephrol 2003;14:469-477.
26. Wahba IM, Mak RH. Obesity and obesity-initiated met-
abolic syndrome: mechanistic links to chronic kidney 
disease. Clin J Am Soc Nephrol 2007;2:550-562.
27. Fogo AB. Mechanisms of progression of chronic kidney 
disease. Pediatr Nephrol 2007;22:2011-2022.
28. Morgado E, Neves PL. Hypertension and chronic kidney 
disease: cause and consequence-therapeutic consider-
ations. In: Babaei H, ed. Antihypertensive Drugs. InTech, 
2012:45-66.
29. Wilcox CS, Welch WJ, Murad F, et al. Nitric oxide synthase 
in macula densa regulates glomerular capillary pressure. 
Proc Natl Acad Sci U S A 1992;89:11993-11997.
30. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir 
MR. Insulin resistance, elevated glomerular filtration 
fraction, and renal injury. Hypertension 1996;28:127-132.
31. Remuzzi G, Perico N, Macia M, Ruggenenti P. The role 
of renin-angiotensin-aldosterone system in the pro-
gression of chronic kidney disease. Kidney Int Suppl 
2005;99:S57-S65.
32. Westhuyzen J, Healy H. Review: biology and relevance of 
C-reactive protein in cardiovascular and renal disease. 
Ann Clin Lab Sci 2000;30:133-143.
33. Yang T, Chou YC, Chu CH, et al. Metabolic syndrome and 
C-reactive protein concentration as independent cor-
relates of chronic kidney disease. Endocr Res 2014;39:94-
98. 
34. Plantinga LC, Johansen KL, Schillinger D, Powe NR. Low-
er socioeconomic status and disability among US adults 
with chronic kidney disease, 1999-2008. Prev Chronic Dis 
2012;9:E12.
35. Averbukh Z, Marcus E, Berman S, et al. Effect of exer-
cise training on glomerular filtration rate of mice with 
various degrees of renal mass reduction. Am J Nephrol 
1992;12:174-178.
Choi H, et al.  Sleep duration and CKD
www.kjim.orghttps://doi.org/10.3904/kjim.2015.400
Supplementary Table 1. Prevalence of indicators of CKD in the study population (n = 1,360)
eGFR, mL/min/1.73 m² No. (%)a
Proteinuria, n (%)b CKDd
Unknownc Negativec Tracec Positive (≥ 1+)c Stage No. (%)c
Total 1,360 (100.0) 7 (0.5) 1,296 (95.3) 42 (3.1) 15 (1.1) All 125 (9.2)
≥ 90 105 (7.7) 0 101 (96.2) 3 (2.9) 1 (1.0) 1 1 (0.1)
60–89 1,140 (83.8) 3 (0.3) 1,098 (96.3) 30 (2.6) 9 (0.8) 2 9 (0.7)
30–59 111 (8.2) 2 (1.8) 95 (85.6) 9 (8.1) 5 (4.5) 3 111 (8.2)
15–29 0 0 0 0 0 4 0
< 15 4 (0.3) 2 (50.0) 2 (50.0) 0 0 5 4 (0.3)
Men 544 (100.0) 2 (0.4) 504 (92.6) 30 (5.5) 8 (1.5) All 52 (9.6)
≥ 90 61 (11.2) 0 57 (93.4) 3 (4.9) 1 (1.6) 1 1 (0.2)
60–89 437 (80.3) 1 (0.2) 409 (93.6) 22 (5.0) 5 (1.1) 2 5 (0.9)
30–59 44 (8.1) 0 37 (84.1) 5 (11.4) 2 (4.5) 3 44 (8.1)
15–29 0 0 0 0 0 4 0
< 15 2 (0.4) 1 (50.0) 1 (50.0) 0 0 5 2 (0.4)
Women 816 (100.0) 5 (0.6) 792 (97.1) 12 (1.5) 7 (0.9) All 73 (8.9)
≥ 90 44 (5.4) 0 44 (100.0) 0 0 1 0
60–89 703 (86.2) 2 (0.3) 689 (98.0) 8 (1.1) 4 (0.6) 2 4 (0.5)
30–59 67 (8.2) 2 (3.0) 58 (86.6) 4 (6.0) 3 (4.5) 3 67 (8.2)
15–29 0 0 0 0 0 4 0
< 15 2 (0.3) 1 (50.0) 1 (50.0) 0 0 5 2 (0.2)
CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate.
aNumber of participants across each kidney function category.
bDefined as proteinuria 1+ or more based on a dipstick urine test.
cNumber of participants with corresponding indicators of CKD across each kidney function category.
dDefined as the presence of at least one of the following factors: eGFR less than 60 mL/min/1.73 m2 or proteinuria. 
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Supplementary Table 2. Age-specific association between sleep duration and CKD criteria in men (n = 544)
Sleep duration
Unadjusted OR (95% CI) Adjusted OR (95% CI)a
   Age < 64 (n = 295)    Age ≥ 64 (n = 249)    Age < 64 (n = 295)    Age ≥ 64 (n = 249)
High creatinine
Continuous, hr/dayb 0.997 (0.629–1.581) 1.075 (0.791–1.461) 1.097 (0.646–1.863) 1.074 (0.747–1.545)
Categorical, hr/day
< 7 0.754 (0.197–2.889) 0.376 (0.115–1.227) 0.336 (0.064–1.770) 0.333 (0.079–1.407)
7 to < 8 1.000 1.000 1.000 1.000
≥ 8 0.980 (0.255–3.771) 0.713 (0.297–1.712) 0.711 (0.137–3.696) 0.724 (0.233–2.246)
Low eGFR
Continuous, hr/dayb 1.135 (0.689–1.871) 1.086 (0.825–1.429) 1.330 (0.757–2.336) 1.134 (0.816–1.577)
Categorical, hr/day
< 7 0.707 (0.154–3.239) 0.576 (0.218–1.523) 0.417 (0.074–2.336) 0.540 (0.150–1.937)
7 to < 8 1.000 1.000 1.000 1.000
≥ 8 1.238 (0.300–5.104) 0.782 (0.349–1.750) 1.129 (0.233–5.465) 0.860 (0.292–2.534)
CKD
Continuous, hr/dayb 1.083 (0.683–1.718) 1.095 (0.842–1.424) 1.259 (0.721–2.199) 1.075 (0.787–1.469)
Categorical, hr/day
< 7 0.754 (0.197–2.889) 0.616 (0.244–1.558) 0.514 (0.105–2.522) 0.608 (0.186–1.988)
7 to < 8 1.000 1.000 1.000 1.000
≥ 8 0.980 (0.255–3.771) 0.841 (0.388–1.823) 0.921 (0.194–4.367) 0.799 (0.289–2.211)
CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate.
aAdjusted model: adjusted for sex, age, body mass index, systolic blood pressure, smoking, alcohol, exercise, diabetes melli-
tus, hypercholesterolemia, depression, history of cardiovascular disease, history of cancer, menopause, socioeconomic status 
(household income, marital status, and working status), and sleep quality (sleep difficulty, sleep awakeness, snoring, and sleep 
apnea).
bContinuous model: association analysis on total sleep duration as a continuous variable.
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Supplementary Table 3. Age-specific association between sleep duration and CKD criteria in women (n = 816)
Sleep duration
Unadjusted OR (95% CI) Adjusted OR (95% CI)a
   Age < 60 (n = 423)    Age ≥ 60 (n = 393)    Age < 60 (n = 423)    Age ≥ 60 (n = 393)
High creatinine
Continuous, hr/dayb 1.337 (0.899-1.988) 1.258 (0.995-1.592) 1.277 (0.837-1.946) 1.224 (0.932-1.607)
Categorical, hr/day
< 7 0.938 (0.280-3.144) 2.076 (0.752-5.734) 0.796 (0.213-2.979) 2.121 (0.627-7.179)
7 to < 8 1.000 1.000 1.000 1.000
≥ 8 1.503 (0.492-4.590) 3.182 (1.256-8.059) 1.289 (0.376-4.416) 3.174 (1.030-9.785)
Low eGFR
Continuous, hr/dayb 1.461 (0.955-2.235) 1.197 (0.970-1.476) 1.469 (0.885-2.441) 1.184 (0.926-1.513)
Categorical, hr/day
< 7 1.132 (0.278-4.615) 1.866 (0.789-4.413) 1.038 (0.221-4.879) 1.741 (0.627-4.832)
7 to < 8 1.000 1.000 1.000 1.000
≥ 8 2.284 (0.653-7.985) 2.587 (1.174-5.703) 2.181 (0.528-9.004) 2.597 (1.018-6.627)
CKD
Continuous, hr/dayb 1.479 (1.000-2.185) 1.210 (0.982-1.491) 1.581 (0.969-2.577) 1.205 (0.945-1.537)
Categorical, hr/day
< 7 0.900 (0.237-3.420) 1.866 (0.789-4.413) 0.852 (0.196-3.704) 1.692 (0.613-4.673)
7 to < 8 1.000 1.000 1.000 1.000
≥ 8 2.374 (0.775-7.273) 2.697 (1.227-5.929) 2.471 (0.687-8.886) 2.699 (1.065-6.841)
CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate.
aAdjusted model: adjusted for sex, age, body mass index, systolic blood pressure, smoking, alcohol, exercise, diabetes melli-
tus, hypercholesterolemia, depression, history of cardiovascular disease, history of cancer, menopause, socioeconomic status 
(household income, marital status, and working status), and sleep quality (sleep difficulty, sleep awakeness, snoring, and sleep 
apnea).
bContinuous model: association analysis on total sleep duration as a continuous variable.
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Supplementary Table 4. Association between sleep duration and CKD criteria after excluding hypertension, diabetes mellitus, 
and cardiovascular disease
Exclusion criteria Total no. No. (%) 
OR, hr/daya
Unadjusted OR (95% CI) Adjusted OR (95% CI)b
High creatinine
Hypertension
Men 332 14 (4.2) 1.186 (0.770–1.829) 1.345 (0.764–2.370)
Women 512 16 (3.1) 1.196 (0.792–1.806) 1.246 (0.697–2.228)
Diabetes mellitus
Men 460 34 (7.4) 1.168 (0.882–1.547) 1.154 (0.837–1.591)
Women 735 46 (6.3) 1.239 (0.979–1.569) 1.127 (0.880–1.444)
Cardiovascular disease
Men 485 31 (6.4) 0.996 (0.751–1.321) 1.012 (0.745–1.373)
Women 772 49 (6.4) 1.289 (1.029–1.614) 1.264 (1.004–1.592)
Low eGFR
Hypertension
Men 332 16 (4.8) 1.076 (0.716–1.618) 1.172 (0.686–2.004)
Women 512 17 (3.3) 1.249 (0.838–1.860) 1.285 (0.701–2.357)
Diabetes mellitus
Men 460 37 (8.0) 1.178 (0.899–1.544) 1.184 (0.867–1.617)
Women 735 55 (7.5) 1.239 (0.997–1.540) 1.110 (0.883–1.397)
Cardiovascular disease
Men 485 34 (7.0) 1.117 (0.853–1.462) 1.129 (0.845–1.508)
Women 772 57 (7.4) 1.247 (1.010–1.539) 1.213 (0.975–1.509)
Low CKD
Hypertension
Men 332 18 (5.4) 1.119 (0.761–1.645) 1.127 (0.705–1.800)
Women 512 18 (3.5) 1.224 (0.829–1.805) 1.267 (0.720–2.229)
Diabetes mellitus
Men 460 39 (8.5) 1.153 (0.885–1.501) 1.136 (0.836–1.545)
Women 735 58 (7.9) 1.248 (1.009–1.543) 1.144 (0.913–1.432)
Cardiovascular disease
Men 485 38 (7.8) 1.083 (0.838–1.399) 1.064 (0.807–1.402)
Women 772 61 (7.9) 1.269 (1.035–1.557) 1.237 (1.000–1.530)
CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate.
aContinuous model: association analysis on total sleep duration as a continuous variable.
bAdjusted model: adjusted for sex, age, body mass index, systolic blood pressure, smoking, alcohol, exercise, diabetes mellitus, 
hypercholesterolemia, depression, history of cancer, menopause, socioeconomic status (household income, marital status, 
and working status), and sleep quality (sleep difficulty, sleep awakeness, snoring, and sleep apnea).
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Supplementary Figure 1. Cubic spline functions of the association between average sleep duration and kidney function accord-
ing to sex. (A) Cubic spline functions of the association between average sleep duration and creatinine in men. (B) Cubic spline 
functions of the association between average sleep duration and creatinine in women. (C) Cubic spline functions of the associ-
ation between average sleep duration and estimated glomerular filtration rate (eGFR) in men. (D) Cubic spline functions of the 
association between average sleep duration and eGFR in women.  The shadowed areas represent 95% confidence intervals for 
the fitted splines. The solid line is a restricted cubic spline. The black dots represent men and the red dots women.
Sleep duration and creatinine in men
Average sleep duration (min)
1.5
1.2
0.9
0.6
240   300 360 420 480  540  600
Cr
ea
tin
in
e (
m
g/
dL
)
Cr
ea
tin
in
e (
m
g/
dL
)
Sleep duration and creatinine in women
Average sleep duration (min)
1.5
1.2
0.9
0.6
240   300 360 420 480  540  600
Sleep duration and eGFR in men
Average sleep duration (min)
100
90
80
70
60
50
40
100
90
80
70
60
50
40
240   300 360 420 480  540  600
eG
FR
 (m
L/
m
in
/1
.7
3 
m
2 )
eG
FR
 (m
L/
m
in
/1
.7
3 
m
2 )
Sleep duration and eGFR  in women
Average sleep duration (min)
240   300 360 420 480  540  600
A
C
B
D
